Zymeworks, Inc. (ZYME)
26.14
-0.72
(-2.68%)
USD |
NASDAQ |
Nov 20, 16:00
26.12
-0.02
(-0.08%)
After-Hours: 20:00
Zymeworks Cash and Short Term Investments (Annual) : 228.80M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 228.80M |
| December 31, 2024 | 225.78M |
| December 31, 2023 | 374.33M |
| December 31, 2022 | 492.23M |
| December 31, 2021 | 252.61M |
| December 31, 2020 | 426.35M |
| Date | Value |
|---|---|
| December 31, 2019 | 298.90M |
| December 31, 2018 | 200.16M |
| December 31, 2017 | 87.80M |
| December 31, 2016 | 40.26M |
| December 31, 2015 | 15.16M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| AbbVie, Inc. | 5.257B |
| Faeth Therapeutics, Inc. | 21.18M |
| ACADIA Pharmaceuticals, Inc. | 819.69M |
| Alnylam Pharmaceuticals, Inc. | 2.908B |
| Anika Therapeutics, Inc. | 57.48M |